Home Stock

Stock Research: Novo Nordisk

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Novo Nordisk

CPSE:NOVO B DK0060534915
1
  • Value
    40
  • Growth
    3
  • Safety
    Safety
    29
  • Combined
    6
  • Sentiment
    14
  • 360° View
    360° View
    1
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Novo Nordisk A/S is a global healthcare company specializing in diabetes care, and the development, manufacturing, and marketing of pharmaceutical products. It operates in the diabetes and obesity care, and biopharmaceuticals industries, with products like NovoLog/NovoRapid and NovoSeven. The company markets its products in over 180 countries, with commercial units in North America and International Operations. In the last fiscal year, the company had a market cap of $300970 million, profits of $34273 million, and revenue of $40321 million, with 76302 employees.

more
Strongest Rank 360° View
Weakest Rank Liquidity
Country Denmark
Industry Pharmaceuticals
Size XX-Large
Website novonordisk.com
Index
OMX C20
Employee Focus EU
Human Rights
Low Waste
Recycling
SDG 11
SDG 12
SDG 13
SDG 17
SDG 3
Novo Nordisk stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 18-Dec-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
40 12 9 12
Growth
3 42 99 69
Safety
Safety
29 26 48 68
Sentiment
14 34 30 8
360° View
360° View
1 7 37 26
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
26 42 28 9
Opinions Change
24 31 52 34
Pro Holdings
n/a 87 82 74
Market Pulse
24 24 15 17
Sentiment
14 34 30 8
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
40 12 9 12
Growth
3 42 99 69
Safety Safety
29 26 48 68
Combined
6 7 54 48
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
51 14 11 17
Price vs. Earnings (P/E)
23 7 7 13
Price vs. Book (P/B)
1 1 1 1
Dividend Yield
88 68 61 61
Value
40 12 9 12
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
10 89 79 61
Profit Growth
44 65 84 54
Capital Growth
6 16 82 29
Stock Returns
3 12 94 92
Growth
3 42 99 69
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
16 25 52 65
Refinancing
3 6 11 12
Liquidity
92 86 85 85
Safety Safety
29 26 48 68

Similar Stocks

Discover high‑ranked alternatives to Novo Nordisk and broaden your portfolio horizons.

BMW

XTRA:BMW
Country: Germany
Industry: Automobile Manufacturers
Size: XX-Large
Full Stock Analysis

Repsol

BME:REP
Country: Spain
Industry: Oil & Gas Integrated
Size: X-Large
Full Stock Analysis

Krka

LJSE:KRKG
Country: Slovenia
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

Prosus

ENXTAM:PRX
Country: Netherlands
Industry: Internet Retail
Size: X-Large
Full Stock Analysis

Frequently Asked
Questions

This is a highly risky stock investment proposition as all consolidated ranks are below-average. There are no compelling arguments to support this stock based on current information. It is not recommended for any investor profile. However, performance does change, so it could we worth keepin on a watchlist.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews